Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Greenwood Genetic Center Diagnostic Laboratories, |
RCV002279970 | SCV002568160 | uncertain significance | not provided | 2022-05-31 | criteria provided, single submitter | clinical testing | PM2 |
Labcorp Genetics |
RCV001280244 | SCV003263280 | uncertain significance | Aspartylglucosaminuria | 2022-10-17 | criteria provided, single submitter | clinical testing | This sequence change replaces serine, which is neutral and polar, with glycine, which is neutral and non-polar, at codon 327 of the AGA protein (p.Ser327Gly). This variant is present in population databases (rs369035792, gnomAD 0.09%). This variant has not been reported in the literature in individuals affected with AGA-related conditions. ClinVar contains an entry for this variant (Variation ID: 991943). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV001280244 | SCV001467406 | uncertain significance | Aspartylglucosaminuria | 2020-04-16 | no assertion criteria provided | clinical testing |